Hari Pujar

641 citations
7 papers · 474 · 1 hit paper · h-index 4

Impact in

    • SARS-CoV-2 and COVID-19 Research
    • Viral gastroenteritis research and epidemiology
  • Microbiology top 10%
    • Bacterial Infections and Vaccines

Papers in

    • Respiratory viral infections research 3
    • Pneumonia and Respiratory Infections 3
    • Pneumocystis jirovecii pneumonia detection and treatment 2
    • Influenza Virus Research Studies 1
    • RNA Interference and Gene Delivery 2
    • Glycosylation and Glycoproteins Research 1

Hari Pujar

6 papers receiving 459 citations

Hari Pujar's Hit Papers

mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials 2019 · 331 citations
3310+2+4Years since publication100200300

Peers

Hari Pujar
Comparison fields: 5 of 53
  • Infectious Diseases 173
  • Microbiology 57
  • Epidemiology 203
  • Immunology 101
  • Animal Science and Zoology 44
Replace Makda S. Gebre with:
Makda S. Gebre United States
Umesh Shaligram India
Christine C. Roberts United States
Robert E. O’Neill United States
Tiequn Zhou Switzerland
Sara L. Bissett United Kingdom
Qingrui Huang China
Jenny Li United States
Keyvan Tadjalli Mehr Germany
Cheryl Callahan United States
Hari Pujar relative to Makda S. Gebre United States Makda S. Gebre's profile →
Citations per field
00.5×2.7×
Makda S. Gebre · 1×
Citations per year

Countries citing papers authored by Hari Pujar

Since Specialization
Citations

This map shows the geographic impact of Hari Pujar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hari Pujar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hari Pujar more than expected).

Fields of papers citing papers by Hari Pujar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hari Pujar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hari Pujar. The network helps show where Hari Pujar may publish in the future.

Co-authors

The 25 scholars most cited alongside Hari Pujar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hari Pujar Line = papers co-authored together Hari Pujar links everyone, so they are left out of the graph.

All Works

7 of 7 papers shown
#Work
1
mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials
Hit paper breakdown →
2019331
2 201983
3 201953
4 20243
5 20242
6 20102
7 20250

About Hari Pujar

Hari Pujar is a scholar working on Epidemiology, Molecular Biology, Oncology, Infectious Diseases and Radiology, Nuclear Medicine and Imaging, having authored 7 papers that have together received 474 indexed citations. Recurring topics across this work include Respiratory viral infections research (3 papers), Pneumonia and Respiratory Infections (3 papers), CAR-T cell therapy research (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), RNA Interference and Gene Delivery (2 papers), Influenza Virus Research Studies (1 paper), Glycosylation and Glycoproteins Research (1 paper) and Monoclonal and Polyclonal Antibodies Research (1 paper). The work is most often cited by research in Infectious Diseases (173 citations), Microbiology (57 citations), Epidemiology (203 citations), Immunology (101 citations) and Animal Science and Zoology (44 citations). Hari Pujar has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Rainard Fuhr, James D. Thompson, Giuseppe Ciaramella, Örn Almarsson, Michael E. Laska, Robert Feldman, Igor Smolenov, Mike Smith, Joseph J. Senn and Michael Watson. Their work appears in journals such as Blood, Human Vaccines & Immunotherapeutics, The Journal of Immunology and Vaccine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact